LARGE [qnco]    
Scale, NOS [medd]    
LONG-TERM FOLLOW-UP [hlca]    
Study [mnob]    
-- Japanese [popg]    
Patients [podg]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Onset [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
objectives [inpr]    
Study [mnob]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
utility [orgt]    
Non-invasive [ftcn]    
predictive [qlco]    
procedures [inpr]    
Fibrosis, Liver [dsyn]    
AST [tmco]    
PLATELET [cell]    
RATIO [qnco]    
Index [inpr]    
SCORE [qnco]    
Following [tmco]    
variables [qlco]    
Body mass index [diap]    
AST [tmco]    
RATIO [qnco]    
Diabetes [dsyn]    
Prediction [idcn]    
HEPATOCELLULAR CARCINOMA [neop]    
large Population [grpa]    
-- Japanese [popg]    
Patients [podg]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Methods [inpr]    
Retrospective Cohort Study [resa]    
Conduct [inbe]    
Study Subject [grup]    
included [ftcn]    
Patients [podg]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Diagnosed [fndg]    
Ultrasonography [diap]    
Median [spco]    
5 6 [fndg]    
YEARS [tmco]    
Primary Endpoint [irda]    
Onset [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Evaluation [hlca]    
Performed [ftcn]    
methodology [inpr]    
Proportional [qlco]    
Hazards [qlco]    
NEW [qlco]    
Cases [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Diagnosed [fndg]    
Study [mnob]    
Cumulative [qlco]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Related [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
YEAR [tmco]    
YEAR [tmco]    
YEAR [tmco]    
Annual [tmco]    
NEW [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Identified [qlco]    
serum AST [lbpr]    
IU/L [qnco]    
Hazard Ratio [qnco]    
CI [geoa]    
Platelet Count [lbpr]    
mU/L [qnco]    
Hazard Ratio [qnco]    
CI [geoa]    
YEARS [tmco]    
Hazard Ratio [qnco]    
CI [geoa]    
Diabetes [dsyn]    
Hazard Ratio [qnco]    
CI [geoa]    
1 - 9% [fndg]    
Independent [idcn]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
considered [idcn]    
FIBROSIS [patf]    
Equivalent [qlco]    
Nonalcoholic Steatohepatitis [dsyn]    
Stage 3 [inpr]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Significantly high [qnco]    
Group [idcn]    
Hazard Ratio [qnco]    
CI [geoa]    
Contrast [irda]    
SCORE [qnco]    
Patients [podg]    
considered [idcn]    
Advanced [qlco]    
FIBROSIS [patf]    
Nonalcoholic Steatohepatitis [dsyn]    
Stage 3 [inpr]    
Associations [menp]    
SCORE [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Observed [ftcn]    
Hazard Ratio [qnco]    
CI [geoa]    
Conclusions [idcn]    
Retrospective Study [resa]    
Annual [tmco]    
Incidence Rate [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
-- Japanese [popg]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Patients [podg]    
Low [qlco]    
Elderly patients [podg]    
Nonalcoholic Fatty Liver Disease [dsyn]    
Diabetes [dsyn]    
AST, ELEVATED [fndg]    
SERUM [bdsu]    
thrombocytopaenia [fndg]    
Suggest [idcn]    
Advanced [qlco]    
Fibrosis, Liver [dsyn]    
monitor [hlca]    
ENSURE [food]    
Early Diagnosis [diap]    
treatment [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
